Eur J Pediatr Surg 2013; 23(05): 375-382
DOI: 10.1055/s-0033-1352529
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Tissue Engineering of Skin for Wound Coverage

Thomas Biedermann
1   Department of Surgery, Tissue Biology Research Unit, University Children's Hospital Zurich, Zurich, Switzerland
,
Sophie Boettcher-Haberzeth
1   Department of Surgery, Tissue Biology Research Unit, University Children's Hospital Zurich, Zurich, Switzerland
2   Pediatric Burn Center, Department of Plastic and Reconstructive Surgery, University Children's Hospital Zurich, Zurich, Switzerland
,
Ernst Reichmann
1   Department of Surgery, Tissue Biology Research Unit, University Children's Hospital Zurich, Zurich, Switzerland
› Author Affiliations
Further Information

Publication History

01 July 2013

02 July 2013

Publication Date:
27 August 2013 (online)

Abstract

Over the past few decades, important milestones have been reached in the field of skin tissue engineering, bringing the ultimate goal of fabricating an autologous dermoepidermal skin substitute with all its cellular components and skin appendages closer to reality. Yet, scientific progress alone is not enough, clinical demands must be addressed and commercial interests need to be fulfilled. This review gives an overview of commercially available skin substitutes for skin replacement therapies and an insight into the recent development of an autologous full-thickness skin substitute that can readily be transplanted in large quantities onto the patient.

 
  • References

  • 1 Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg 2007; 120 (2) 26e-40e
  • 2 Kryger ZB, Bauer BS. Surgical management of large and giant congenital pigmented nevi of the lower extremity. Plast Reconstr Surg 2008; 121 (5) 1674-1684
  • 3 Schiestl C, Stiefel D, Meuli M. Giant naevus, giant excision, eleg(i)ant closure? Reconstructive surgery with Integra Artificial Skin to treat giant congenital melanocytic naevi in children. J Plast Reconstr Aesthet Surg 2010; 63 (4) 610-615
  • 4 Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 2007; 4 (9) e234
  • 5 Berman B, Viera MH, Amini S, Huo R, Jones IS. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 2008; 19 (4) 989-1006
  • 6 Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3 (5) 349-363
  • 7 Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994; 220 (1) 10-18
  • 8 Wilgus TA. Regenerative healing in fetal skin: a review of the literature. Ostomy Wound Manage 2007; 53 (6) 16-31 , quiz 32–33
  • 9 Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 2010; 126 (4) 1172-1180
  • 10 Zhong SP, Zhang YZ, Lim CT. Tissue scaffolds for skin wound healing and dermal reconstruction. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010; 2 (5) 510-525
  • 11 van der Veen VC, Boekema BK, Ulrich MM, Middelkoop E. New dermal substitutes. Wound Repair Regen 2011; 19 (Suppl. 01) s59-s65
  • 12 O'Connor N, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 1 (8211) 75-78
  • 13 Gallico III GG, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984; 311 (7) 448-451
  • 14 Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986; 1 (8490) 1123-1124
  • 15 Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns 2007; 33 (4) 405-413
  • 16 Krupp S, Benathan M, Meuli M , et al. Current concepts in pediatric burn care: management of burn wounds with cultured epidermal autografts. Eur J Pediatr Surg 1992; 2 (4) 210-215
  • 17 Gobet R, Raghunath M, Altermatt S , et al. Efficacy of cultured epithelial autografts in pediatric burns and reconstructive surgery. Surgery 1997; 121 (6) 654-661
  • 18 Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns 2006; 32 (4) 395-401
  • 19 Meuli M, Raghunath M. Burns (Part 2). Tops and flops using cultured epithelial autografts in children. Pediatr Surg Int 1997; 12 (7) 471-477
  • 20 Horch RE, Kopp J, Kneser U, Beier J, Bach AD. Tissue engineering of cultured skin substitutes. J Cell Mol Med 2005; 9 (3) 592-608
  • 21 Wood FM, Stoner ML, Fowler BV, Fear MW. The use of a non-cultured autologous cell suspension and Integra dermal regeneration template to repair full-thickness skin wounds in a porcine model: a one-step process. Burns 2007; 33 (6) 693-700
  • 22 Navarro FA, Stoner ML, Park CS , et al. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model. J Burn Care Rehabil 2000; 21 (6) 513-518
  • 23 MacNeil S. Progress and opportunities for tissue-engineered skin. Nature 2007; 445 (7130) 874-880
  • 24 Burke JF, Yannas IV, Quinby Jr WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194 (4) 413-428
  • 25 Heitland A, Piatkowski A, Noah EM, Pallua N. Update on the use of collagen/glycosaminoglycate skin substitute-six years of experiences with artificial skin in 15 German burn centers. Burns 2004; 30 (5) 471-475
  • 26 Frame JD, Still J, Lakhel-LeCoadou A , et al. Use of dermal regeneration template in contracture release procedures: a multicenter evaluation. Plast Reconstr Surg 2004; 113 (5) 1330-1338
  • 27 Branski LK, Herndon DN, Pereira C , et al. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 2007; 35 (11) 2615-2623
  • 28 Stiefel D, Schiestl C, Meuli M. Integra Artificial Skin for burn scar revision in adolescents and children. Burns 2010; 36 (1) 114-120
  • 29 Shakespeare PG. The role of skin substitutes in the treatment of burn injuries. Clin Dermatol 2005; 23 (4) 413-418
  • 30 Kearney JN. Clinical evaluation of skin substitutes. Burns 2001; 27 (5) 545-551
  • 31 Haslik W, Kamolz LP, Nathschläger G, Andel H, Meissl G, Frey M. First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 2007; 33 (3) 364-368
  • 32 Bannasch H, Unterberg T, Föhn M, Weyand B, Horch RE, Stark GB. Cultured keratinocytes in fibrin with decellularised dermis close porcine full-thickness wounds in a single step. Burns 2008; 34 (7) 1015-1021
  • 33 Chu CS, McManus AT, Matylevich NP, Goodwin CW, Pruitt Jr BA. Integra as a dermal replacement in a meshed composite skin graft in a rat model: a one-step operative procedure. J Trauma 2002; 52 (1) 122-129
  • 34 Jung SN, Chung JW, Yim YM, Kwon H. One-stage skin grafting of the exposed skull with acellular human dermis (AlloDerm). J Craniofac Surg 2008; 19 (6) 1660-1662
  • 35 Haslik W, Kamolz LP, Manna F, Hladik M, Rath T, Frey M. Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm. J Plast Reconstr Aesthet Surg 2010; 63 (2) 360-364
  • 36 Ryssel H, Germann G, Kloeters O, Gazyakan E, Radu CA. Dermal substitution with Matriderm(®) in burns on the dorsum of the hand. Burns 2010; 36 (8) 1248-1253
  • 37 Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RL, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12 (2) 243-248
  • 38 Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 2007; 33 (8) 946-957
  • 39 Wong T, McGrath JA, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 2007; 156 (6) 1149-1155
  • 40 Mansbridge J. Commercial considerations in tissue engineering. J Anat 2006; 209 (4) 527-532
  • 41 Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211 (4486) 1052-1054
  • 42 Edmonds M ; European and Australian Apligraf Diabetic Foot Ulcer Study Group. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8 (1) 11-18
  • 43 Barber C, Watt A, Pham C , et al. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. J Wound Care 2008; 17 (12) 517-527
  • 44 Waymack P, Duff RG, Sabolinski M ; The Apligraf Burn Study Group. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. Burns 2000; 26 (7) 609-619
  • 45 Boyce ST, Kagan RJ, Yakuboff KP , et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 2002; 235 (2) 269-279
  • 46 Boyce ST. Design principles for composition and performance of cultured skin substitutes. Burns 2001; 27 (5) 523-533
  • 47 Pontiggia L, Biedermann T, Meuli M , et al. Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation. J Invest Dermatol 2009; 129 (2) 480-490
  • 48 Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A 1998; 95 (7) 3902-3907
  • 49 Webb A, Li A, Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation 2004; 72 (8) 387-395
  • 50 Biedermann T, Pontiggia L, Böttcher-Haberzeth S , et al. Human eccrine sweat gland cells can reconstitute a stratified epidermis. J Invest Dermatol 2010; 130 (8) 1996-2009
  • 51 Hartmann-Fritsch F, Biedermann T, Braziulis E, Meuli M, Reichmann E. A new model for preclinical testing of dermal substitutes for human skin reconstruction. Pediatr Surg Int 2013; 29 (5) 479-488
  • 52 Böttcher-Haberzeth S, Klar AS, Biedermann T , et al. “Trooping the color”: restoring the original donor skin color by addition of melanocytes to bioengineered skin analogs. Pediatr Surg Int 2013; 29 (3) 239-247
  • 53 Sahota PS, Burn JL, Heaton M , et al. Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen 2003; 11 (4) 275-284
  • 54 Black AF, Berthod F, L'heureux N, Germain L, Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 1998; 12 (13) 1331-1340
  • 55 Schechner JS, Nath AK, Zheng L , et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A 2000; 97 (16) 9191-9196
  • 56 Supp DM, Wilson-Landy K, Boyce ST. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J 2002; 16 (8) 797-804
  • 57 Chen X, Aledia AS, Ghajar CM , et al. Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A 2009; 15 (6) 1363-1371
  • 58 Montaño I, Schiestl C, Schneider J , et al. Formation of human capillaries in vitro: the engineering of prevascularized matrices. Tissue Eng Part A 2010; 16 (1) 269-282
  • 59 Metcalfe AD, Ferguson MW. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials 2007; 28 (34) 5100-5113